Feinmesser R L, Gray K, Means A R, Chantry A
Department of Biochemistry, Charing Cross and Westminster Medical School, London, UK.
Oncogene. 1996 Jun 20;12(12):2725-30.
Calmodulin-dependent protein kinase II (Cam kinase II) is known to desensitise epidermal growth factor receptor (HER-1) tyrosine kinase activity by a process involving phosphorylation at serines 1046/47 in the cytoplasmic tail. We have developed an experimental system to investigate phosphorylation of the related HER-2/c-erbB2 proto-oncogene utilising purified Cam kinase II and recombinant glutathione-S-transferase (GST) fusion proteins. The cDNA for rat Cam kinase II-alpha was transfected into human embryonic kidney (HEK) 293 fibroblasts and the expressed protein purified to homogeneity by calmodulin-agarose affinity chromatography. A GST fusion protein comprising residues 1126-1255 of HER-2 was phosphorylated by purified Cam kinase II, in contrast to a GST protein comprising residues 1005-1125. Phosphoamino-acid analysis and site-directed mutagenesis indicated that HER-2 was phosphorylated on a single site at threonine-1172 which resides within a consensus Cam kinase II phosphorylation site (RAKT). HER-2 (threonine-1172-alanine), in the form of a ligand-inducible chimaera HER-1/2, was co-transfected into HEK-293 fibroblasts with a constitutively active form of Cam kinase II, followed by in vivo labelling of these cells with 32 P-orthophosphate. Immunoprecipitation of ligand-activated receptors followed by two-dimensional phosphopeptide mapping indicated that threonine-1172 in HER-2 is a newly identified in vivo site which can be hyper-phosphorylated by constitutively active Cam kinase II. In addition, when over-expressed in HEK-293 fibroblasts, HER-1/2 (threonine-1172-alanine) showed a defect in desensitisation and underwent a more sustained EGF-induced receptor autophosphorylation compared to wild-type HER-1/2.
已知钙调蛋白依赖性蛋白激酶II(钙调蛋白激酶II)通过涉及细胞质尾部丝氨酸1046/47磷酸化的过程使表皮生长因子受体(HER-1)酪氨酸激酶活性脱敏。我们开发了一个实验系统,利用纯化的钙调蛋白激酶II和重组谷胱甘肽-S-转移酶(GST)融合蛋白来研究相关HER-2/c-erbB2原癌基因的磷酸化。将大鼠钙调蛋白激酶II-α的cDNA转染到人胚肾(HEK)293成纤维细胞中,通过钙调蛋白-琼脂糖亲和层析将表达的蛋白纯化至同质。与包含1005-1125残基的GST蛋白相比,包含HER-2的1126-1255残基的GST融合蛋白被纯化的钙调蛋白激酶II磷酸化。磷酸氨基酸分析和定点诱变表明,HER-2在苏氨酸-1172的单个位点被磷酸化,该位点位于钙调蛋白激酶II磷酸化共有位点(RAKT)内。HER-2(苏氨酸-1172-丙氨酸)以配体诱导嵌合体HER-1/2的形式与组成型活性钙调蛋白激酶II共转染到HEK-293成纤维细胞中,然后用32P-正磷酸盐对这些细胞进行体内标记。对配体激活受体进行免疫沉淀,随后进行二维磷酸肽图谱分析,结果表明HER-2中的苏氨酸-1172是一个新鉴定的体内位点,可被组成型活性钙调蛋白激酶II过度磷酸化。此外,当在HEK-293成纤维细胞中过表达时,与野生型HER-1/2相比,HER-1/2(苏氨酸-1172-丙氨酸)在脱敏方面存在缺陷,并且经历了更持久的表皮生长因子诱导的受体自身磷酸化。